Dosing (loading and maintenance) for preferred antibiotics according to type of infusion used (intermittent, extended or continuous)
| . | Used by . | Loading dosea (when administered) . | Missingb . | Maintenance dose per 24 ha . | Missingb . |
|---|---|---|---|---|---|
| Vancomycin II | 276 | 23 (19–25) | 2 | 25 (15–25) | 9 |
| Vancomycin CI | 126 | 15 (13–20) | 6 | 25 (25–30) | 11 |
| Piperacillin/tazobactam II | 291 | 4.5 (4.5–4.5) | 0 | 18 (14.6–18) | 3 |
| Piperacillin/tazobactam EI | 83 | 4.5 (4.5–4.5) | 0 | 18 (13.5–18) | 2 |
| Piperacillin/tazobactam CI | 28 | 4.5 (4.5–4.5) | 0 | 18 (15.8–18) | 0 |
| Meropenem II | 268 | 2 (1–2) | 2 | 3 (3–3) | 7 |
| Meropenem EI | 111 | 2 (1–2) | 0 | 3 (3–6) | 1 |
| Meropenem CI | 17 | 1 (1–2) | 0 | 4 (3–5) | 0 |
| . | Used by . | Loading dosea (when administered) . | Missingb . | Maintenance dose per 24 ha . | Missingb . |
|---|---|---|---|---|---|
| Vancomycin II | 276 | 23 (19–25) | 2 | 25 (15–25) | 9 |
| Vancomycin CI | 126 | 15 (13–20) | 6 | 25 (25–30) | 11 |
| Piperacillin/tazobactam II | 291 | 4.5 (4.5–4.5) | 0 | 18 (14.6–18) | 3 |
| Piperacillin/tazobactam EI | 83 | 4.5 (4.5–4.5) | 0 | 18 (13.5–18) | 2 |
| Piperacillin/tazobactam CI | 28 | 4.5 (4.5–4.5) | 0 | 18 (15.8–18) | 0 |
| Meropenem II | 268 | 2 (1–2) | 2 | 3 (3–3) | 7 |
| Meropenem EI | 111 | 2 (1–2) | 0 | 3 (3–6) | 1 |
| Meropenem CI | 17 | 1 (1–2) | 0 | 4 (3–5) | 0 |
II, intermittent infusion (duration <2 h); EI, extended infusion (duration 2–4 h); CI, continuous infusion (24 h infusion).
Percentages were calculated on the number of respondents for each antibiotic. Dosing values are shown as median (IQR).
aVancomycin doses are in mg/kg; piperacillin/tazobactam and meropenem doses are in g.
bNumber of missing values for each dosing category.
Dosing (loading and maintenance) for preferred antibiotics according to type of infusion used (intermittent, extended or continuous)
| . | Used by . | Loading dosea (when administered) . | Missingb . | Maintenance dose per 24 ha . | Missingb . |
|---|---|---|---|---|---|
| Vancomycin II | 276 | 23 (19–25) | 2 | 25 (15–25) | 9 |
| Vancomycin CI | 126 | 15 (13–20) | 6 | 25 (25–30) | 11 |
| Piperacillin/tazobactam II | 291 | 4.5 (4.5–4.5) | 0 | 18 (14.6–18) | 3 |
| Piperacillin/tazobactam EI | 83 | 4.5 (4.5–4.5) | 0 | 18 (13.5–18) | 2 |
| Piperacillin/tazobactam CI | 28 | 4.5 (4.5–4.5) | 0 | 18 (15.8–18) | 0 |
| Meropenem II | 268 | 2 (1–2) | 2 | 3 (3–3) | 7 |
| Meropenem EI | 111 | 2 (1–2) | 0 | 3 (3–6) | 1 |
| Meropenem CI | 17 | 1 (1–2) | 0 | 4 (3–5) | 0 |
| . | Used by . | Loading dosea (when administered) . | Missingb . | Maintenance dose per 24 ha . | Missingb . |
|---|---|---|---|---|---|
| Vancomycin II | 276 | 23 (19–25) | 2 | 25 (15–25) | 9 |
| Vancomycin CI | 126 | 15 (13–20) | 6 | 25 (25–30) | 11 |
| Piperacillin/tazobactam II | 291 | 4.5 (4.5–4.5) | 0 | 18 (14.6–18) | 3 |
| Piperacillin/tazobactam EI | 83 | 4.5 (4.5–4.5) | 0 | 18 (13.5–18) | 2 |
| Piperacillin/tazobactam CI | 28 | 4.5 (4.5–4.5) | 0 | 18 (15.8–18) | 0 |
| Meropenem II | 268 | 2 (1–2) | 2 | 3 (3–3) | 7 |
| Meropenem EI | 111 | 2 (1–2) | 0 | 3 (3–6) | 1 |
| Meropenem CI | 17 | 1 (1–2) | 0 | 4 (3–5) | 0 |
II, intermittent infusion (duration <2 h); EI, extended infusion (duration 2–4 h); CI, continuous infusion (24 h infusion).
Percentages were calculated on the number of respondents for each antibiotic. Dosing values are shown as median (IQR).
aVancomycin doses are in mg/kg; piperacillin/tazobactam and meropenem doses are in g.
bNumber of missing values for each dosing category.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
